Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the ac...
Saved in:
Published in | The Lancet global health Vol. 9; no. 12; pp. e1740 - e1749 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.12.2021
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children.
In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs.
Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009).
Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life.
Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. |
---|---|
AbstractList | The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children.BACKGROUNDThe risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children.In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs.METHODSIn this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs.Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009).FINDINGSBetween March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009).Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life.INTERPRETATIONInfants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life.Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.FUNDINGBill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; p =0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; p =0·0009). Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. Methods: In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Findings: Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Interpretation: Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Funding: Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. |
Author | Martinez, Leonardo Stadler, Attie Workman, Lesley Zar, Heather J Botha, Maresa Wedderburn, Catherine J Nicol, Mark P le Roux, David M |
Author_xml | – sequence: 1 givenname: Leonardo surname: Martinez fullname: Martinez, Leonardo organization: Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA – sequence: 2 givenname: Mark P surname: Nicol fullname: Nicol, Mark P organization: Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia – sequence: 3 givenname: Catherine J surname: Wedderburn fullname: Wedderburn, Catherine J organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa – sequence: 4 givenname: Attie surname: Stadler fullname: Stadler, Attie organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa – sequence: 5 givenname: Maresa surname: Botha fullname: Botha, Maresa organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa – sequence: 6 givenname: Lesley surname: Workman fullname: Workman, Lesley organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa – sequence: 7 givenname: David M surname: le Roux fullname: le Roux, David M organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa – sequence: 8 givenname: Heather J surname: Zar fullname: Zar, Heather J email: heather.zar@uct.ac.za organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34798032$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9uFCEUxiemxtbaR9BwWRNXYWBnGC9qmo1_mjTxojXxjpyBww51FrbArNkX8Xmd2a2b9kpCAvn48R1y-F4WRz54LIrXjL5nlFUfbsqSiRmjzc_zkr2lVNB6xp4VJwf56NH-uDhL6Y6Oo2l4WdcvimMu6kZSXp4UfxbbHFa4hD5sXBwSAX0_uOSyC564aVrwekvAG5I7JNGlXyRYkocWox76kFwixiWEhBOvO9ebLgTzkQDpg1-6PBjnoSeti7kjOnQhZpJGdTvxC1gjuQ2__TtyE4YRuLTRaXhVPLfQJzx7WE-LH18-3y6-za6_f71aXF7P9JzzPOMl4xLaWpq2qa0VvBEtomgBEBpt27rijaVcGMaNpbrSYm44ldxQMEKA5afF1d7XBLhT6-hWELcqgFM7IcSlgpid7lFRAXVTVgI1t0LMWyktSmNkrXktKoaj18Xeaz20KzQafY7QPzF9euJdp5Zho2RFm1Ky0eD8wSCG-wFTViuXNPY9eAxDUmVFaSnnDRUjOt-jOoaUItpDGUbVFBG1i4ia_l-VTO0ioqYSbx6_8XDrXyBG4NMewLHrG4dRJe3QazQuos5jW9x_SvwFMefRnw |
CitedBy_id | crossref_primary_10_3389_fpubh_2024_1359663 crossref_primary_10_1038_s41467_022_34061_7 crossref_primary_10_1016_j_cell_2023_11_002 crossref_primary_10_1093_cid_ciad268 crossref_primary_10_1016_j_actatropica_2023_106987 crossref_primary_10_1016_j_ijid_2022_02_005 crossref_primary_10_1016_S2214_109X_22_00283_2 crossref_primary_10_3389_fimmu_2023_1193058 crossref_primary_10_1093_ofid_ofad487 crossref_primary_10_1016_S2214_109X_21_00466_6 crossref_primary_10_3389_fimmu_2023_1122048 crossref_primary_10_1016_j_jinf_2023_01_002 crossref_primary_10_1093_infdis_jiac179 crossref_primary_10_1093_ofid_ofad449 crossref_primary_10_3389_fpubh_2023_1292762 crossref_primary_10_1016_j_ijtb_2023_11_002 crossref_primary_10_1164_rccm_202208_1543OC crossref_primary_10_1111_imr_13116 crossref_primary_10_1016_j_jvacx_2023_100267 crossref_primary_10_1016_j_celrep_2022_110896 crossref_primary_10_1016_j_vaccine_2023_06_020 crossref_primary_10_1016_S2213_2600_24_00083_3 |
Cites_doi | 10.1038/nri.2016.38 10.1016/S2055-6640(20)30456-8 10.1371/journal.pone.0222399 10.1172/jci.insight.130090 10.1371/journal.pone.0194186 10.1016/j.humimm.2004.02.014 10.1128/CVI.00385-08 10.1128/CVI.00203-06 10.1093/oxfordjournals.aje.a121593 10.2307/2529620 10.1016/S0140-6736(14)60195-1 10.2105/AJPH.88.1.15 10.1016/0895-4356(95)00510-2 10.1136/bmjopen-2019-033259 10.1093/cid/civ581 10.1086/527418 10.1016/0895-4356(95)00048-8 10.1016/S2214-109X(14)70245-1 10.1164/rccm.201601-0116LE 10.1016/S2352-4642(17)30149-9 10.1016/S0140-6736(20)30166-5 10.1136/thoraxjnl-2014-206242 10.3389/fped.2019.00233 10.1016/S2213-2600(17)30497-6 10.12688/f1000research.14184.2 10.1093/infdis/152.2.243 10.1016/S1473-3099(04)01202-2 10.1542/peds.74.1.121 10.1183/13993003.02245-2018 10.1002/rmv.1862 10.1183/13993003.03028-2020 |
ContentType | Journal Article |
Copyright | 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 |
Copyright_xml | – notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. – notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/S2214-109X(21)00407-1 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 2214-109X |
EndPage | e1749 |
ExternalDocumentID | oai_doaj_org_article_04a79264ec3f445b88fe8dd87c37461e 10_1016_S2214_109X_21_00407_1 34798032 S2214109X21004071 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | South Africa |
GeographicLocations_xml | – name: South Africa |
GrantInformation | Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust. |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: Wellcome Trust grantid: 203525/Z/16/Z – fundername: NHGRI NIH HHS grantid: U54 HG009824 – fundername: NIAID NIH HHS grantid: U01 AI110466 |
GroupedDBID | .1- .FO 0R~ 0SF 1P~ 457 53G 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ACHQT ADBBV ADEZE AENEX AEVXI AEXQZ AFCTW AFRHN AFTJW AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HZ~ IPNFZ IXB KQ8 M41 M~E NCXOZ O9- OD. OK1 OO~ RIG ROL SSZ Z5R AAMRU ADVLN AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c533t-32138ab78db97ff4394bee4baaea9cfb7639f034d13df0c6c45d3083d0ad44af3 |
IEDL.DBID | IXB |
ISSN | 2214-109X |
IngestDate | Sun Sep 29 07:15:54 EDT 2024 Tue Sep 17 21:25:40 EDT 2024 Sun Aug 18 16:32:22 EDT 2024 Thu Sep 26 18:04:16 EDT 2024 Fri Oct 18 09:22:04 EDT 2024 Sat Feb 24 15:48:35 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c533t-32138ab78db97ff4394bee4baaea9cfb7639f034d13df0c6c45d3083d0ad44af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S2214109X21004071 |
PMID | 34798032 |
PQID | 2600285904 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_04a79264ec3f445b88fe8dd87c37461e pubmedcentral_primary_oai_pubmedcentral_nih_gov_8609281 proquest_miscellaneous_2600285904 crossref_primary_10_1016_S2214_109X_21_00407_1 pubmed_primary_34798032 elsevier_sciencedirect_doi_10_1016_S2214_109X_21_00407_1 |
PublicationCentury | 2000 |
PublicationDate | 2021-12-01 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The Lancet global health |
PublicationTitleAlternate | Lancet Glob Health |
PublicationYear | 2021 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Moss, Khan (bib10) 2004; 65 Graham, Cuevas, Jean-Philippe (bib22) 2015; 61 Dupont, Reeves (bib31) 2016; 26 Farhat, Greenaway, Pai, Menzies (bib36) 2006; 10 Martinez, Cords, Horsburgh, Andrews (bib3) 2020; 395 Fang, Fan, Yang (bib28) 2009; 16 Klenerman, Oxenius (bib11) 2016; 16 Cobelens, Nagelkerke, Fletcher (bib8) 2018; 7 Fletcher, Snowden, Landry (bib12) 2016; 7 Rockhill, Newman, Weinberg (bib26) 1998; 88 Gandhi, Khanna (bib29) 2004; 4 Wilkinson, Oni, Gideon, Goliath, Wilkinson, Riou (bib13) 2016; 193 Zar, Barnett, Myer, Stein, Nicol (bib16) 2015; 70 Gupta, Rosenberg, Eriksen (bib33) 2019; 54 Breslow (bib25) 1974; 30 Miles, Sande, Kaye (bib32) 2008; 197 Whittaker, López-Varela, Broderick, Seddon (bib35) 2019; 7 Pass, Hutto, Reynolds, Polhill (bib30) 1984; 74 Peduzzi, Concato, Feinstein, Holford (bib24) 1995; 48 Martinez, le Roux, Barnett, Stadler, Nicol, Zar (bib17) 2018; 2 Jenkins, Tolman, Yuen (bib2) 2014; 383 Madrid, Varo, Maculuve (bib20) 2018; 13 Kampmann, Whittaker (bib7) 2016 Concato, Peduzzi, Holford, Feinstein (bib23) 1995; 48 Zar, Pellowski, Cohen (bib18) 2019; 14 Martinez, Shen, Handel (bib5) 2018; 6 Mandalakas, Hesseling, Kay (bib6) 2021; 57 (bib21) 2014 Stockdale, Nash, Farmer (bib34) 2020; 221 Pass (bib9) 1985; 152 Müller, Tanner, Matsumiya (bib15) 2019; 4 Seale, MacIntyre, Gidding, Backhouse, Dwyer, Gilbert (bib27) 2006; 13 Bates, Brantsaeter (bib14) 2016; 2 Pellowski, Wedderburn, Stadler (bib19) 2019; 9 Dodd, Gardiner, Coghlan, Seddon (bib1) 2014; 2 Comstock, Livesay, Woolpert (bib4) 1974; 99 34798013 - Lancet Glob Health. 2021 Dec;9(12):e1636-e1637 34800373 - Lancet Glob Health. 2021 Nov 17 Müller (10.1016/S2214-109X(21)00407-1_bib15) 2019; 4 Pellowski (10.1016/S2214-109X(21)00407-1_bib19) 2019; 9 Breslow (10.1016/S2214-109X(21)00407-1_bib25) 1974; 30 Dupont (10.1016/S2214-109X(21)00407-1_bib31) 2016; 26 Fletcher (10.1016/S2214-109X(21)00407-1_bib12) 2016; 7 Moss (10.1016/S2214-109X(21)00407-1_bib10) 2004; 65 Wilkinson (10.1016/S2214-109X(21)00407-1_bib13) 2016; 193 Seale (10.1016/S2214-109X(21)00407-1_bib27) 2006; 13 Fang (10.1016/S2214-109X(21)00407-1_bib28) 2009; 16 Zar (10.1016/S2214-109X(21)00407-1_bib16) 2015; 70 Miles (10.1016/S2214-109X(21)00407-1_bib32) 2008; 197 Cobelens (10.1016/S2214-109X(21)00407-1_bib8) 2018; 7 Madrid (10.1016/S2214-109X(21)00407-1_bib20) 2018; 13 Martinez (10.1016/S2214-109X(21)00407-1_bib17) 2018; 2 Kampmann (10.1016/S2214-109X(21)00407-1_bib7) 2016 Pass (10.1016/S2214-109X(21)00407-1_bib30) 1984; 74 Zar (10.1016/S2214-109X(21)00407-1_bib18) 2019; 14 Rockhill (10.1016/S2214-109X(21)00407-1_bib26) 1998; 88 Martinez (10.1016/S2214-109X(21)00407-1_bib3) 2020; 395 Mandalakas (10.1016/S2214-109X(21)00407-1_bib6) 2021; 57 Concato (10.1016/S2214-109X(21)00407-1_bib23) 1995; 48 Martinez (10.1016/S2214-109X(21)00407-1_bib5) 2018; 6 Jenkins (10.1016/S2214-109X(21)00407-1_bib2) 2014; 383 Gandhi (10.1016/S2214-109X(21)00407-1_bib29) 2004; 4 Pass (10.1016/S2214-109X(21)00407-1_bib9) 1985; 152 Bates (10.1016/S2214-109X(21)00407-1_bib14) 2016; 2 Farhat (10.1016/S2214-109X(21)00407-1_bib36) 2006; 10 Comstock (10.1016/S2214-109X(21)00407-1_bib4) 1974; 99 Dodd (10.1016/S2214-109X(21)00407-1_bib1) 2014; 2 Whittaker (10.1016/S2214-109X(21)00407-1_bib35) 2019; 7 Klenerman (10.1016/S2214-109X(21)00407-1_bib11) 2016; 16 Stockdale (10.1016/S2214-109X(21)00407-1_bib34) 2020; 221 Gupta (10.1016/S2214-109X(21)00407-1_bib33) 2019; 54 Graham (10.1016/S2214-109X(21)00407-1_bib22) 2015; 61 Peduzzi (10.1016/S2214-109X(21)00407-1_bib24) 1995; 48 |
References_xml | – volume: 7 start-page: 233 year: 2019 ident: bib35 article-title: Examining the complex relationship between tuberculosis and other infectious diseases in children publication-title: Front Pediatr contributor: fullname: Seddon – start-page: 31 year: 2016 end-page: 45 ident: bib7 article-title: Immunology of tuberculosis in children publication-title: Handbook of child and adolescent tuberculosis contributor: fullname: Whittaker – volume: 193 start-page: 1307 year: 2016 end-page: 1310 ident: bib13 article-title: Activation profile of publication-title: Am J Respir Crit Care Med contributor: fullname: Riou – volume: 16 start-page: 1700 year: 2009 end-page: 1703 ident: bib28 article-title: Incidence of cytomegalovirus infection in Shanghai, China publication-title: Clin Vaccine Immunol contributor: fullname: Yang – volume: 48 start-page: 1503 year: 1995 end-page: 1510 ident: bib24 article-title: Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates publication-title: J Clin Epidemiol contributor: fullname: Holford – volume: 7 start-page: 280 year: 2018 ident: bib8 article-title: The convergent epidemiology of tuberculosis and human cytomegalovirus infection publication-title: F1000 Res contributor: fullname: Fletcher – volume: 10 start-page: 1192 year: 2006 end-page: 1204 ident: bib36 article-title: False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? publication-title: Int J Tuberc Lung Dis contributor: fullname: Menzies – volume: 2 start-page: e453 year: 2014 end-page: e459 ident: bib1 article-title: Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study publication-title: Lancet Glob Health contributor: fullname: Seddon – year: 2014 ident: bib21 article-title: Guidance for national tuberculosis programmes on the management of tuberculosis in children – volume: 65 start-page: 456 year: 2004 end-page: 464 ident: bib10 article-title: CD8(+) T-cell immunity to cytomegalovirus publication-title: Hum Immunol contributor: fullname: Khan – volume: 30 start-page: 89 year: 1974 end-page: 99 ident: bib25 article-title: Covariance analysis of censored survival data publication-title: Biometrics contributor: fullname: Breslow – volume: 7 year: 2016 ident: bib12 article-title: T-cell activation is an immune correlate of risk in BCG vaccinated infants publication-title: Nat Commun contributor: fullname: Landry – volume: 61 start-page: S179 year: 2015 end-page: S187 ident: bib22 article-title: Clinical case definitions for classification of intrathoracic tuberculosis in children: an update publication-title: Clin Infect Dis contributor: fullname: Jean-Philippe – volume: 221 start-page: 1127 year: 2020 end-page: 1134 ident: bib34 article-title: Cytomegalovirus antibody responses associated with increased risk of tuberculosis disease in Ugandan adults publication-title: J Infect Dis contributor: fullname: Farmer – volume: 57 year: 2021 ident: bib6 article-title: Tuberculosis prevention in children: a prospective community-based study in South Africa publication-title: Eur Respir J contributor: fullname: Kay – volume: 70 start-page: 592 year: 2015 end-page: 594 ident: bib16 article-title: Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study publication-title: Thorax contributor: fullname: Nicol – volume: 383 start-page: 1572 year: 2014 end-page: 1579 ident: bib2 article-title: Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates publication-title: Lancet contributor: fullname: Yuen – volume: 6 start-page: 276 year: 2018 end-page: 286 ident: bib5 article-title: Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda publication-title: Lancet Respir Med contributor: fullname: Handel – volume: 4 start-page: 725 year: 2004 end-page: 738 ident: bib29 article-title: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments publication-title: Lancet Infect Dis contributor: fullname: Khanna – volume: 48 start-page: 1495 year: 1995 end-page: 1501 ident: bib23 article-title: Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy publication-title: J Clin Epidemiol contributor: fullname: Feinstein – volume: 152 start-page: 243 year: 1985 end-page: 248 ident: bib9 article-title: Epidemiology and transmission of cytomegalovirus publication-title: J Infect Dis contributor: fullname: Pass – volume: 99 start-page: 131 year: 1974 end-page: 138 ident: bib4 article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence publication-title: Am J Epidemiol contributor: fullname: Woolpert – volume: 14 year: 2019 ident: bib18 article-title: Maternal health and birth outcomes in a South African birth cohort study publication-title: PLoS One contributor: fullname: Cohen – volume: 13 start-page: 1181 year: 2006 end-page: 1184 ident: bib27 article-title: National serosurvey of cytomegalovirus in Australia publication-title: Clin Vaccine Immunol contributor: fullname: Gilbert – volume: 197 start-page: 658 year: 2008 end-page: 662 ident: bib32 article-title: CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study publication-title: J Infect Dis contributor: fullname: Kaye – volume: 2 start-page: 46 year: 2018 end-page: 55 ident: bib17 article-title: Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa publication-title: Lancet Child Adolesc Health contributor: fullname: Zar – volume: 74 start-page: 121 year: 1984 end-page: 126 ident: bib30 article-title: Increased frequency of cytomegalovirus infection in children in group day care publication-title: Pediatrics contributor: fullname: Polhill – volume: 88 start-page: 15 year: 1998 end-page: 19 ident: bib26 article-title: Use and misuse of population attributable fractions publication-title: Am J Public Health contributor: fullname: Weinberg – volume: 26 start-page: 75 year: 2016 end-page: 89 ident: bib31 article-title: Cytomegalovirus latency and reactivation: recent insights into an age old problem publication-title: Rev Med Virol contributor: fullname: Reeves – volume: 4 year: 2019 ident: bib15 article-title: Cytomegalovirus infection is a risk factor for tuberculosis disease in infants publication-title: JCI Insight contributor: fullname: Matsumiya – volume: 2 start-page: 136 year: 2016 end-page: 142 ident: bib14 article-title: Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen publication-title: J Virus Erad contributor: fullname: Brantsaeter – volume: 54 year: 2019 ident: bib33 article-title: Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study publication-title: Eur Respir J contributor: fullname: Eriksen – volume: 16 start-page: 367 year: 2016 end-page: 377 ident: bib11 article-title: T cell responses to cytomegalovirus publication-title: Nat Rev Immunol contributor: fullname: Oxenius – volume: 9 year: 2019 ident: bib19 article-title: Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape publication-title: BMJ Open contributor: fullname: Stadler – volume: 13 year: 2018 ident: bib20 article-title: Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: a cross-sectional survey publication-title: PLoS One contributor: fullname: Maculuve – volume: 395 start-page: 973 year: 2020 end-page: 984 ident: bib3 article-title: The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis publication-title: Lancet contributor: fullname: Andrews – volume: 16 start-page: 367 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib11 article-title: T cell responses to cytomegalovirus publication-title: Nat Rev Immunol doi: 10.1038/nri.2016.38 contributor: fullname: Klenerman – volume: 2 start-page: 136 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib14 article-title: Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen publication-title: J Virus Erad doi: 10.1016/S2055-6640(20)30456-8 contributor: fullname: Bates – volume: 221 start-page: 1127 year: 2020 ident: 10.1016/S2214-109X(21)00407-1_bib34 article-title: Cytomegalovirus antibody responses associated with increased risk of tuberculosis disease in Ugandan adults publication-title: J Infect Dis contributor: fullname: Stockdale – volume: 14 year: 2019 ident: 10.1016/S2214-109X(21)00407-1_bib18 article-title: Maternal health and birth outcomes in a South African birth cohort study publication-title: PLoS One doi: 10.1371/journal.pone.0222399 contributor: fullname: Zar – volume: 4 year: 2019 ident: 10.1016/S2214-109X(21)00407-1_bib15 article-title: Cytomegalovirus infection is a risk factor for tuberculosis disease in infants publication-title: JCI Insight doi: 10.1172/jci.insight.130090 contributor: fullname: Müller – volume: 13 year: 2018 ident: 10.1016/S2214-109X(21)00407-1_bib20 article-title: Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: a cross-sectional survey publication-title: PLoS One doi: 10.1371/journal.pone.0194186 contributor: fullname: Madrid – volume: 65 start-page: 456 year: 2004 ident: 10.1016/S2214-109X(21)00407-1_bib10 article-title: CD8(+) T-cell immunity to cytomegalovirus publication-title: Hum Immunol doi: 10.1016/j.humimm.2004.02.014 contributor: fullname: Moss – volume: 16 start-page: 1700 year: 2009 ident: 10.1016/S2214-109X(21)00407-1_bib28 article-title: Incidence of cytomegalovirus infection in Shanghai, China publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00385-08 contributor: fullname: Fang – volume: 13 start-page: 1181 year: 2006 ident: 10.1016/S2214-109X(21)00407-1_bib27 article-title: National serosurvey of cytomegalovirus in Australia publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00203-06 contributor: fullname: Seale – volume: 99 start-page: 131 year: 1974 ident: 10.1016/S2214-109X(21)00407-1_bib4 article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a121593 contributor: fullname: Comstock – volume: 30 start-page: 89 year: 1974 ident: 10.1016/S2214-109X(21)00407-1_bib25 article-title: Covariance analysis of censored survival data publication-title: Biometrics doi: 10.2307/2529620 contributor: fullname: Breslow – volume: 383 start-page: 1572 year: 2014 ident: 10.1016/S2214-109X(21)00407-1_bib2 article-title: Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates publication-title: Lancet doi: 10.1016/S0140-6736(14)60195-1 contributor: fullname: Jenkins – volume: 88 start-page: 15 year: 1998 ident: 10.1016/S2214-109X(21)00407-1_bib26 article-title: Use and misuse of population attributable fractions publication-title: Am J Public Health doi: 10.2105/AJPH.88.1.15 contributor: fullname: Rockhill – volume: 48 start-page: 1495 year: 1995 ident: 10.1016/S2214-109X(21)00407-1_bib23 article-title: Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(95)00510-2 contributor: fullname: Concato – volume: 9 year: 2019 ident: 10.1016/S2214-109X(21)00407-1_bib19 article-title: Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape publication-title: BMJ Open doi: 10.1136/bmjopen-2019-033259 contributor: fullname: Pellowski – volume: 10 start-page: 1192 year: 2006 ident: 10.1016/S2214-109X(21)00407-1_bib36 article-title: False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? publication-title: Int J Tuberc Lung Dis contributor: fullname: Farhat – volume: 61 start-page: S179 issue: suppl 3 year: 2015 ident: 10.1016/S2214-109X(21)00407-1_bib22 article-title: Clinical case definitions for classification of intrathoracic tuberculosis in children: an update publication-title: Clin Infect Dis doi: 10.1093/cid/civ581 contributor: fullname: Graham – volume: 197 start-page: 658 year: 2008 ident: 10.1016/S2214-109X(21)00407-1_bib32 article-title: CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study publication-title: J Infect Dis doi: 10.1086/527418 contributor: fullname: Miles – volume: 48 start-page: 1503 year: 1995 ident: 10.1016/S2214-109X(21)00407-1_bib24 article-title: Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(95)00048-8 contributor: fullname: Peduzzi – volume: 2 start-page: e453 year: 2014 ident: 10.1016/S2214-109X(21)00407-1_bib1 article-title: Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(14)70245-1 contributor: fullname: Dodd – volume: 193 start-page: 1307 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib13 article-title: Activation profile of Mycobacterium tuberculosis-specific CD4(1) T cells reflects disease activity irrespective of HIV status publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201601-0116LE contributor: fullname: Wilkinson – volume: 2 start-page: 46 year: 2018 ident: 10.1016/S2214-109X(21)00407-1_bib17 article-title: Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa publication-title: Lancet Child Adolesc Health doi: 10.1016/S2352-4642(17)30149-9 contributor: fullname: Martinez – volume: 395 start-page: 973 year: 2020 ident: 10.1016/S2214-109X(21)00407-1_bib3 article-title: The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(20)30166-5 contributor: fullname: Martinez – volume: 70 start-page: 592 year: 2015 ident: 10.1016/S2214-109X(21)00407-1_bib16 article-title: Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study publication-title: Thorax doi: 10.1136/thoraxjnl-2014-206242 contributor: fullname: Zar – volume: 7 start-page: 233 year: 2019 ident: 10.1016/S2214-109X(21)00407-1_bib35 article-title: Examining the complex relationship between tuberculosis and other infectious diseases in children publication-title: Front Pediatr doi: 10.3389/fped.2019.00233 contributor: fullname: Whittaker – volume: 6 start-page: 276 year: 2018 ident: 10.1016/S2214-109X(21)00407-1_bib5 article-title: Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(17)30497-6 contributor: fullname: Martinez – volume: 7 start-page: 280 year: 2018 ident: 10.1016/S2214-109X(21)00407-1_bib8 article-title: The convergent epidemiology of tuberculosis and human cytomegalovirus infection publication-title: F1000 Res doi: 10.12688/f1000research.14184.2 contributor: fullname: Cobelens – volume: 152 start-page: 243 year: 1985 ident: 10.1016/S2214-109X(21)00407-1_bib9 article-title: Epidemiology and transmission of cytomegalovirus publication-title: J Infect Dis doi: 10.1093/infdis/152.2.243 contributor: fullname: Pass – volume: 4 start-page: 725 year: 2004 ident: 10.1016/S2214-109X(21)00407-1_bib29 article-title: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(04)01202-2 contributor: fullname: Gandhi – volume: 74 start-page: 121 year: 1984 ident: 10.1016/S2214-109X(21)00407-1_bib30 article-title: Increased frequency of cytomegalovirus infection in children in group day care publication-title: Pediatrics doi: 10.1542/peds.74.1.121 contributor: fullname: Pass – volume: 54 year: 2019 ident: 10.1016/S2214-109X(21)00407-1_bib33 article-title: Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study publication-title: Eur Respir J doi: 10.1183/13993003.02245-2018 contributor: fullname: Gupta – volume: 26 start-page: 75 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib31 article-title: Cytomegalovirus latency and reactivation: recent insights into an age old problem publication-title: Rev Med Virol doi: 10.1002/rmv.1862 contributor: fullname: Dupont – volume: 57 year: 2021 ident: 10.1016/S2214-109X(21)00407-1_bib6 article-title: Tuberculosis prevention in children: a prospective community-based study in South Africa publication-title: Eur Respir J doi: 10.1183/13993003.03028-2020 contributor: fullname: Mandalakas – start-page: 31 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib7 article-title: Immunology of tuberculosis in children contributor: fullname: Kampmann – volume: 7 year: 2016 ident: 10.1016/S2214-109X(21)00407-1_bib12 article-title: T-cell activation is an immune correlate of risk in BCG vaccinated infants publication-title: Nat Commun contributor: fullname: Fletcher |
SSID | ssj0000993277 |
Score | 2.4472432 |
Snippet | The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well... Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are... |
SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e1740 |
SubjectTerms | Child Child, Preschool Cohort Studies Cytomegalovirus Infections - complications Cytomegalovirus Infections - diagnosis Female Humans Infant Infant, Newborn Longitudinal Studies Male Prospective Studies Real-Time Polymerase Chain Reaction South Africa - epidemiology Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - etiology |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gI8WZ5yUgcQCI0fmzscIMVVYUEF6i0N8tPNahNSjap1D_C78VjZ5cNHHpBinJILCfOjGe-2DPzIfSKAUzlghaOcVNwJ6IdtPFURefqJbPUJ7KJL1-r4xP-eb1c71F9QUxYLg-cP9xhybWoo9f2lgXOl0bK4KVzUlgmeEV8sr5kufcz9SPjHkYT7SKlhEdbU6__pO8cfttdfE3JG9BjUZCZY0r1-2f-6V_8-XcY5Z5fOrqDbk-AEn_IA7mLbvj2HrqVV-NwTjK6j36trobu3Edv0F02_bjB2v4cmxyuhRs4AlhZrFuHIyLEEHCOu4CH0fjejmfdptngaS8H2tttQeT3WOOzDjiPRgf8Wtg0_XCKgXa3H3CqXQvtV_rCY1jIfosTZx_O9EQP0MnRp--r42JiZChshIVDwShhUhshnalFCJBVa7znRmuvaxtMNFZ1KBl3hLlQ2srypWMR5LlSO851YA_RQdu1_jHCNIjKcC60IbGD0tS2qnxteF3RUlsuF-jdVhzqIhfeULuINJAf7J2vFSUqyU-RBfoIQts1hrrZ6ULUJjVpk7pOmxZIbkWuJgiSoUXsqrnu-S-3KqLiFIV9F936btwo4ACAOoElX6BHWWV2bwmJvLJkdIHETJlmw5jfaZvTVAZcVmVNJXnyP8b9FN2kEKyT4nSeoYOhH_3ziLYG8yJNrN9iuCWR priority: 102 providerName: Directory of Open Access Journals |
Title | Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa |
URI | https://dx.doi.org/10.1016/S2214-109X(21)00407-1 https://www.ncbi.nlm.nih.gov/pubmed/34798032 https://www.proquest.com/docview/2600285904/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC8609281 https://doaj.org/article/04a79264ec3f445b88fe8dd87c37461e |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9UwEA7LPgki3j1elgg-KFhPmuQ0qW_uwWUR9EUX-hZydQtre-xpBf-Iv9dM2h6tPghC6UOapmlnOjMkM9-H0DMGYSoXNHOMm4w7Ee2gjaciOlcvmaU-kU28_1CcX_B31aY6Qtu5FgbSKifbP9r0ZK2nlvX0Nde7ul5_pBRyFMuKAugZSXXkgO0JRXzV6WGdJUZAjCYCRuifwQ2_CnnGQVLjc5q_SONk-cJFJST_haf6OxL9M6HyNw91dhPdmEJL_Gac_S105Jvb6Pq4LofHcqM76Mf2e99-8dEvtN_qbthjbb8O9Zi4hWs4AthbrBuHY2yIIfUctwH3g_GdHa7afb3H064O9LczNPJrrPFVC-xHgwOmLWzqrr_EQMDb9Tih2EL_rd55DEvaL3Fi78MjUdFddHH29tP2PJu4GTIbA8Q-YzRnUhshnSlFCFBfa7znRmuvSxtMNFtlIIy7nLlAbGH5xrEY7jmiHec6sHvouGkb_wBhGkRhOBfa5HEAYkpbFL40vCwo0ZbLFXo1i0PtRggOdchNA_nBLnqlaK6S_FS-QqcgtENnQNBODW33WU0qpAjXoozRoLcscL4xUgYvnZPCMsGL3K-QnEWuFgoZh6r_9fyns4qo-LPCDoxufDvsFbABAGIg4St0f1SZwyyhpFcSRldILJRp8RrLK019mQDBZUFKKvOH_z_lR-gahWSdlKfzGB333eCfxGirNydpleIk_VQ_ASZ6JuA |
link.rule.ids | 230,315,786,790,870,891,2115,3525,27955,27956,45907 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcgAJId6Ep5E4gETYxPYmDje6olqg7YVWys3ys41UkiWbIPFH-L14nGQhcEBCWu3BsR3vzmTmiz0zH0IvKMBUlpPYUKZiZnJvB7X_yrxztZxqYgPZxPFJtj5jH8tluYdWUy4MhFWOtn-w6cFajy2L8d9cbKpq8ZkQiFEsSgJFzxLII7_Clv5dD7L4yoPdRouHQJQEBkYYEMOIX5k8wyyh8SVJX4WJ4nTmo0Ip_5mr-huK_hlR-ZuLOryJbozYEr8bln8L7dn6Nro-bMzhId_oDvqx-t41X6x3DM23qu23WOqvfTVEbuEKPg4MLpa1wR4cYog9x43DXa9sq_vLZltt8XisA_31VBv5LZb4sgH6o94A1RZWVdtdYGDgbTscythC_5XcWAx72q9xoO_DA1PRXXR2-P50tY5HcoZYe4TYxZSklEuVc6OK3DlIsFXWMiWllYV2ytutwiWUmZQal-hMs6WhHu-ZRBrGpKP30H7d1PYBwsTlmWIslyr1EySq0FlmC8WKjCRSMx6hN5M4xGaowSF2wWkgPzhGLwVJRZCfSCN0AELbdYYS2qGhac_FqEMiYTIvPBy0mjrGlopzZ7kxPNc0Z1lqI8QnkYuZRvqpqn_d__mkIsI_rXAEI2vb9FsBdABQMjBhEbo_qMxulZDTyxNKIpTPlGn2M-ZX6uoiVATnWVIQnj78_yU_Q1fXp8dH4ujDyadH6BqByJ0QtPMY7Xdtb5946NWpp-HR-gkTpSkQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytomegalovirus+acquisition+in+infancy+and+the+risk+of+tuberculosis+disease+in+childhood%3A+a+longitudinal+birth+cohort+study+in+Cape+Town%2C+South+Africa&rft.jtitle=The+Lancet+global+health&rft.au=Martinez%2C+Leonardo&rft.au=Nicol%2C+Mark+P&rft.au=Wedderburn%2C+Catherine+J&rft.au=Stadler%2C+Attie&rft.date=2021-12-01&rft.issn=2214-109X&rft.eissn=2214-109X&rft.volume=9&rft.issue=12&rft.spage=e1740&rft_id=info:doi/10.1016%2FS2214-109X%2821%2900407-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-109X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-109X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-109X&client=summon |